Graphite Bio Inc (GRPH) PT Lowered to $12 at BofA Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts GRPH Hot Sheet
Price: $3.18 --0%
Rating Summary:
0 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 22 | New: 0
Rating Summary:
0 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 22 | New: 0
Join SI Premium – FREE
BofA Securities analyst Geoff Meacham lowered the price target on Graphite Bio Inc (NASDAQ: GRPH) to $12.00 (from $24.00) while maintaining a Buy rating.
You May Also Be Interested In
- Morgan Stanley Upgrades Aixtron SE (AIXA:GR) (AIXXF) to Overweight
- Life Time Group Holdings Inc (LTH) PT Raised to $55 at KeyBanc
- Standard Chartered Plc. (STAN:LN) (SCBFF) PT Raised to GBP24.25 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
